VHCP Management as of March 31, 2015
Portfolio Holdings for VHCP Management
VHCP Management holds 19 positions in its portfolio as reported in the March 2015 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Juno Therapeutics | 22.2 | $97M | 1.7M | 55.40 | |
| Anacor Pharmaceuticals In | 15.6 | $68M | 1.2M | 57.85 | |
| Avalanche Biotechnologies In | 12.8 | $56M | 1.4M | 40.52 | |
| Dbv Technologies (DBVTF) | 7.1 | $31M | 694k | 44.41 | |
| Gw Pharmaceuticals Plc ads | 6.5 | $28M | 312k | 91.13 | |
| Coherus Biosciences (CHRS) | 5.9 | $26M | 870k | 29.61 | |
| Zafgen | 4.9 | $21M | 542k | 39.61 | |
| Dyax | 3.8 | $17M | 1.0M | 16.75 | |
| Heron Therapeutics (HRTX) | 3.6 | $16M | 1.1M | 14.55 | |
| BioCryst Pharmaceuticals (BCRX) | 3.6 | $16M | 1.7M | 9.03 | |
| Ascendis Pharma A S (ASND) | 3.2 | $14M | 811k | 17.36 | |
| Flamel Technologies | 2.1 | $9.0M | 500k | 17.98 | |
| Alcobra | 1.9 | $8.4M | 1.5M | 5.63 | |
| D Stemline Therapeutics | 1.5 | $6.5M | 451k | 14.47 | |
| Therapeuticsmd | 1.2 | $5.1M | 847k | 6.05 | |
| Cynapsus Therapeutics | 1.2 | $5.1M | 5.9M | 0.87 | |
| Lipocine | 1.1 | $4.6M | 670k | 6.90 | |
| Zs Pharma | 1.0 | $4.2M | 100k | 42.08 | |
| Ocera Therapeutics | 0.8 | $3.3M | 704k | 4.71 |
